Healio

Adding nelarabine to hyper-CVAD appears safe, effective in adults with T-ALL

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — The addition of nelarabine to a standard hyper-CVAD regimen demonstrated durable overall response ...
ascopubs.org

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.

Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. Forty-five patients were enrolled; 25 patients ...
ascopubs.org

Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia

Randomized Trial of Bone Marrow Versus Lenograstim-Primed Blood Cell Allogeneic Transplantation in Patients With Early-Stage Leukemia: A Report From the Société Française de Greffe de Moelle PURPOSE: ...
Medscape

Should There Be a Standard Therapy for Mantle Cell Lymphoma?

The MD Anderson group initially described results with Hyper-CVAD/MA, [28] a more intensive regimen that includes hyperfractionated cyclophosphamide and alternating high-dose methotrexate–cytarabine ...
Nature

The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

Forty patients with T-ALL/LL were enrolled with a median age of 38 years (19–78 years). Twenty-three patients (58%) had T-ALL and 17 (43%) had LL. The performance status was ⩽2 in 36/40 (90%) patients ...